Results 201 to 210 of about 11,201 (278)

Deep intronic <i>MSH2</i> variant confirms Muir-Torre subtype of Lynch syndrome. [PDF]

open access: yesJID Innov
Chan-Pak-Choon F   +5 more
europepmc   +1 more source

The scale matters: A review on stimuli‐responsive microrobots categorized by scale for biomedical applications

open access: yesResponsive Materials, EarlyView.
We systematically summarize how each scale dictates fundamental choices in design feature, manufacturing technology, driving mechanism, and control strategy, which are inherently governed by scale‐dominated physical principles. Furthermore, the application of scale‐determined operation modes of microrobots across different stages of medical ...
Hang Yin   +3 more
wiley   +1 more source

Adenoid cystic carcinoma with cystic change of the parotid gland posing a diagnostic challenge: A rare case report. [PDF]

open access: yesInt J Surg Case Rep
Wubalem SM   +5 more
europepmc   +1 more source

Second primary tumors in patients with retinoblastoma: a review of the literature [PDF]

open access: yes, 1997
Abramson D H   +30 more
core   +2 more sources

Immune escape mechanisms revealed by multifunctional nanoprobes targeting PD‐L1 in hepatic cancer progression

open access: yesVIEW, EarlyView.
The ICGB@Apt nanoprobes are designed to specifically recognize immune checkpoint molecules such as PD‐L1, thereby enabling precise monitoring of the progression from liver cirrhosis to HC. By binding to PD‐L1 on tumor cells, ICGB@Apt visualizes immune escape events and tumor metastasis while simultaneously reflecting the dynamic interaction between ...
Yiteng Meng   +5 more
wiley   +1 more source

Fatty Acid Synthase as a Potential Metabolic Vulnerability in Ocular Adnexal Sebaceous Carcinoma. [PDF]

open access: yesCancers (Basel)
Berlied A   +5 more
europepmc   +1 more source

Cell membrane‐coated nanoparticles for dermatological diseases

open access: yesVIEW, EarlyView.
Skin disorders are challenging to treat due to complex barrier functions and limited conventional therapies. Biomimetic cell membrane‐coated nanoparticles (CM‐NPs) offer a superior nanomedicine approach by evading immune detection and enabling precise targeting.
Shuaijun Zou, Baojie Zhang, Yuanjie Zhu
wiley   +1 more source

Home - About - Disclaimer - Privacy